San Diego – May 20, 2015 – Cooley advised HTG Molecular Diagnostics, Inc. on its initial public offering. HTG is a commercial stage company that develops and markets a novel technology platform to facilitate the routine use of complex molecular profiling. The company trades on The NASDAQ Global Market under the symbol "HTGM."

The Cooley corporate securities team advising HTG included partners Wainwright Fishburn and Steve Przesmicki and associates Wade Andrews, Asa Henin, Matt Robbins and Sunny Chang.

Support for the offering was provided by partners Natasha Leskovsek and Wendy Goldstein and special counsel Phil Mitchell (health care and life sciences regulatory); partner Susan Cooper Philpot, senior counsel Bill Morrow and associate Todd Gluth (tax); and associate Megan Arthur (compensation and benefits).

About Cooley LLP

Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.